Therefore, its not uncommon to have to pay full out-of-pocket costs for this medication
For formulations, reformulate outside the 462 patents scopeditch propylene glycol, shift pH beyond 6.5-8.5
- Journal your journey Daily check-ins, reflection prompts, and mood tracking
Additionally, these discounts can be stacked together
[1][2] Why CVS Caremark Chose Wegovy Novo Nordisk deal: CVS Caremark negotiated preferred pricing for Wegovy, making it their primary GLP-1 option Zepbound removed: Eli Lilly's Zepbound was dropped from CVS Caremark formularies in July 2025 Cardiovascular benefit: Wegovy is the only GLP-1 FDA-approved for both weight loss AND cardiovascular risk reduction What This Means for Aetna Members Standard Aetna plans: Wegovy is covered with prior authorization Self-funded employer plans: May have different formulariescheck with HR Medicare Advantage: Coverage varies by plansee Medicare guide For more details on how CVS Caremark affects GLP-1 coverage across all insurers: Complete CVS Caremark Guide Now that you understand why Wegovy is preferred, here's what you need for prior authorization approval

Based on Lilly's pricing for Zepbound (tirzepatide) and industry analyst estimates, retatrutide is expected to cost approximately $349-499/month through manufacturer direct-to-consumer programs like LillyDirect, with list prices likely exceeding ,000/month